Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes

Sheng Zhou(St. Jude Children's Research Hospital), Brian P. Sorrentino(St. Jude Children's Research Hospital), Yang Du(Uniformed Services University of the Health Sciences), Yong‐Dong Wang(St. Jude Children's Research Hospital), Zhijun Ma(St. Jude Children's Research Hospital), Soghra Fatima(St. Jude Children's Research Hospital), Taihe Lu(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital)
Molecular Therapy
March 9, 2016
10.1038/mt.2016.55
Cited by 42

Related Papers

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
|Cell|2014|562
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
|Nature|2019|445
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs
|Cell|2023|407
The genetic basis and cell of origin of mixed phenotype acute leukaemia
|Nature|2018|383